The Pharmaceutical Pricing and Reimbursement systems established by Member States are usually quite complex.
Each country uses different schemes and policies, adapted to its own economic and health needs.
Because we are aware of the complexity of health economics and different modeling, we offer you scientific and medical approach focusing on patient needs and health-related quality of life/utility, understanding market evolution and politics, which is supported with lots of experiences in reimbursement applications and preparation of cost effectiveness and budget impact models.
Operation title: BILLEV FARMACIJA VZHOD digitalizacija
Link to the European Cohesion Policy website: www.eu-skladi.si
“The investment is co-funded by the Republic of Slovenia and the European Union from the European Regional Development Fund”. – Read more
Operation title: BILLEV FARMACIJA VZHOD digitalizacija Link to the European Cohesion Policy website: www.eu-skladi.si
“The investment is co-funded by the Republic of Slovenia and the European Union from the European Regional Development Fund.” – Read more